Laddar...
Normal antibody response after COVID-19 during treatment with cladribine
Cladribine is a highly effective, recently available treatment in multiple sclerosis. This case report describes a patient with COVID-19 infection during second year treatment with cladribine. The infection was mild and she was able to mount an adequate immune response with detectable antibodies thr...
Sparad:
| I publikationen: | Mult Scler Relat Disord |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier B.V.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7832623/ https://ncbi.nlm.nih.gov/pubmed/32882501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102476 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|